SUBSCRIBE
SUBSCRIBE

Rituximab Ups Survival in Chronic Lymphocytic Leukemia (CLL), University of Cologne Study

October 1, 2010 | 
1 min read

MedPageToday -- Adding the monoclonal antibody rituximab (Rituxan) to initial chemotherapy significantly improved progression-free and overall survival in patients with chronic lymphocytic leukemia (CLL), a prospective study found.

Europe
MORE ON THIS TOPIC
Sign outside BioNTech's building in Germany
Breast cancer
BioNTech Builds Case for PD-L1/VEGF Bispecific With Promising Breast Cancer Data
December 11, 2024
 · 
2 min read
 · 
Tristan Manalac
A handshake of businessmen. Modern design with a positive context. Concept of help, support, and agreement between businessmen. Modern art collage, trendy magazine style.
Mergers & acquisitions
Novo, Catalent $16.5B Deal Wins EU Blessing as US Antitrust Scrutiny Mounts
December 9, 2024
 · 
2 min read
 · 
Tristan Manalac
Facade of Novo Nordisk's office in Fremont, California
Manufacturing
Novo Continues Manufacturing Spending Spree With $400M Denmark Expansion, $200M Plant Purchase
December 5, 2024
 · 
2 min read
 · 
Tristan Manalac
Sanofi's Distribution Center in Quebec, Canada
Radiopharmaceuticals
Sanofi Inks $326M Radiopharma Deal With Orano
October 17, 2024
 · 
2 min read
 · 
Tristan Manalac